Abstract
Achieving adequate oral immunosuppression in a renal transplant patient who develops short bowel syndrome provides a significant challenge. We report a case where oral tacrolimus has been used to provide immunosuppression in an established renal transplant patient who developed short bowel syndrome secondary to mesenteric infarction. After reviewing the literature, we conclude that tacrolimus can be used as first-line immunosuppression in patients with short bowel syndrome.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sen PK, Kinare G, Engineer SD, Parulkar GB (1963) The middle aortic syndrome. Brit Heart J 25:610
Novelli M, Muiesan P, Mieli-Vergani G, Dhawan A, Rela M, Heaton N (1999) Oral absorption of tacrolimus in children with intestinal failure due to short or absent bowel. Transpl Int 12:463
Thielke J, Martin J, Weber FL, Schroeder TJ, Goretsky S, Hanto DW (1998) Pharmacokinetics of tacrolimus and cyclosporine in short bowel syndrome. Liver Transpl Surg 5:432
Regazzi M, Alessiani M, Reggiani P, et al. (1997) Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation. Transplant Proc 29:1857
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Patel, N., Smith, S., Handa, A. et al. The use of oral tacrolimus in a case of short bowel syndrome. Transpl Int 17, 44–45 (2004). https://doi.org/10.1007/s00147-003-0606-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00147-003-0606-2